Clinical trials
Observational Lymphadenopathy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 4 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Far Eastern Memorial Hospital | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| American College of Radiology Imaging Network | 1 |
| Broncus Technologies | 1 |
| Central Hospital, Nancy, France | 1 |
| Chimei Medical Center | 1 |
| Erasmus Medical Center | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Massachusetts General Hospital | 1 |
| Mauna Kea Technologies | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphadenopathy | 18 |
| Lymphoma | 4 |
| Lung Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Sarcoidosis | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Adenoma, Islet Cell | 1 |
| Adrenal Gland Neoplasms | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.